Neoplasms Metastasis Completed Phase 2 Trials for Capecitabine (DB01101)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00629148Sequential Versus Simultaneous Use of Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer (MBC)Treatment
NCT00444678Cetuximab, Capecitabine and Oxaliplatin in Patients With Epidermal Growth Factor Receptor (EGFr) Expressing Metastatic Colorectal CancerTreatment
NCT00123851Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal CancerTreatment
NCT00125021Tarceva and Capecitabine for Pancreatic CancerTreatment
NCT00142038Docetaxel and Capecitabine in Advanced Gastric CancerTreatment
NCT00270491Capecitabine Associated With Weekly Paclitaxel in Metastatic Breast Cancer.Treatment
NCT02004769Trastuzumab Plus Docetaxel and Capecitabine For First Line Treatment of Her2-Positive Advanced Gastric CancerTreatment